• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medicare anti-fraud bill takes aim at corporations

Medicare anti-fraud bill takes aim at corporations

September 23, 2010 By MassDevice staff

Healthcare reform

The U.S. House passed a bill with bipartisan support yesterday that would give the Dept. of Health and Human Services more power in prosecuting corporations that commit Medicare or Medicaid fraud.

The Strengthening Medicare Anti-Fraud Measures Act, introduced by Rep. Pete Stark (D-Calif.) and Rep. Wally Herger (R-Calif.) would give the HHS Office of the Inspector General the power to exclude the parent companies of subsidiaries who commit Medicare fraud from participating in the federal benefits program. The ban could also hold for executives who commit fraud, even if their conviction or guilty plea takes place after a departure from their companies.

Medicare is the biggest healthcare payer in the country. Barring its payments to any company would significantly reduce its ability to participate in the healthcare industry.

Reps. Ron Klein (D-Fla.) and Ileana Ros-Lehtinen (R-Fla.) also pushed for the bill.

"Our seniors depend on Medicare services, and I won’t stand to see those services eroded by thieves who cheat the system," Klein said in prepared remarks released after the House vote.

The federal government has been ramping up its Medicare fraud prosecution in recent years. The Dept. of Justice collected $1.6 billion from busts of Medicare and Medicaid fraud rings, off-label marketing and illegal promotion of drugs and devices in fiscal year 2009. In June, HHS and the DOJ reached out to states attorneys general for help in cracking down on Medicare fraud; a month later the two agencies announced a takedown of 94 individuals charged with $251 million in fraudulent claims to Medicare. Earlier this week, the Centers for Medicare and Medicaid Services proposed new fraud prevention regulations that would require the screening of healthcare providers based on their level of risk.

Filed Under: News Well Tagged With: Centers for Medicare and Medicaid Services (CMS)

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy